Bluegate buys 58% of Elron Ventures for $55.2M at 100% premium
What's the deal? Elron Ventures (TASE: ELRN) said controlling shareholder Arieli EL has accepted an offer from the Melnik family's Bluegate Capital to buy its 58% stake for US$46M — a 100% premium over the market price when the offer was made. The buyout is not directed at public shareholders, but Elron's stock has gained about 28% since the offer surfaced.
Why now? The sale lets Arieli EL repay a US$23M loan from Phoenix FinancialDealroom has a profile for this one. Try Dealroom → taken to buy control of Elron in July 2024. After Elron's share price fell, Arieli EL breached the loan's terms, and Phoenix pushed for early repayment. Arieli will still exit with a profit in the tens of millions of shekels.
The backstory: The deal follows a dispute among Arieli's partners. On one side stood Evan Renov and Eric Bentov; on the other, Lisya Bahar-Manoah, whom they had appointed chairperson. The three each hold a one-third stake and could not agree on resolving the Phoenix loan, leading to Bahar-Manoah's removal as chairperson, though she remains on the board.
New leadership: Bluegate, backed by the New York-based Melnik family, which has a prior connection to Renov's family, plans to appoint Micah Lakin Avni as chairperson. Avni is chief executive officer of non-bank lender PeninsulaDealroom has a profile for this one. Try Dealroom → and was previously a partner at Jerusalem Global VenturesDealroom has a profile for this one. Try Dealroom →.
What's the endgame? Elron describes itself as focused on defence tech, deep tech, cybersecurity, and AI, with an M&A strategy aimed at dual-use technologies. It has announced a plan with Rafael for up to $300 million of acquisitions over three years, subject to approvals and financing. Historically it worked in medical devices, software, and cyber, with exits including Given ImagingDealroom has a profile for this one. Try Dealroom → and CartiHeal.
What could go wrong? The sale resets control but does not guarantee continuity of strategy. The buyer's ability to maintain the Rafael-backed acquisition plan — and fund it — is a key open question.
The signal: The US$46M price implies an Elron valuation of roughly US$79.3M, about double its market capitalisation when the offer emerged. The deal underscores how Israeli investment firms are repositioning toward defence and dual-use technology — while showing how debt pressure and partner disputes can force a control reset.
Read more: en.globes.co.il
Image credit: "Removed canopies on Colmore Gate, Bull Street" by ell brown, licensed under CC BY 2.0